KOR
Stem Cell Therapy
-
Stem cell therapy promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. It is the next chapter in organ transplantation and uses cells instead of donor organs, which are limited in supply.
In 1996, Cellontech developed and commercialized the first ACI (Autologous Chondrocyte Implantation) product in Asia, which was also approved as the first product being labeled as 'Bioengineering Product' by Ministry of Food and Drug Safety in 2001. Customized to meet the needs of each patient, Cellontech aims to provide easy access and the optimal solution to the OA patients.